Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide

Computational analysis of naturally occurring resistance-associated substitutions in genes NS3, NS5A, and NS5B among 86 subtypes of hepatitis C virus worldwide

Ruihong Wu,1 Dongfeng Geng,2 Xiumei Chi,1 Xiaomei Wang,1 Xiuzhu Gao,1 Hongqin Xu,1 Ying Shi,1 Yazhe Guan,1 Yang Wang,1 Jinglan Jin,1 Yanhua Ding,3 Junqi Niu1 1Department of Hepatology, First Hospital of Jilin University, Changchun, Jilin Province 130021, People’s Republic of China; 2Centre...

Full description

Bibliographic Details
Main Authors:	Wu R, Geng D, Chi X, Wang X, Gao X, Xu H, Shi Y, Guan Y, Wang Y, Jin J, Ding Y, Niu J
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-09-01
Series:	Infection and Drug Resistance
Subjects:	hepatitis C virus direct-acting antiviral resistance-associated substitution subtype
Online Access:	https://www.dovepress.com/computational-analysis-of-naturally-occurring-resistance-associated-su-peer-reviewed-article-IDR

Similar Items

Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection
by: Pooneh Rahimi, et al.
Published: (2021-01-01)

Subtype-Specific Prevalence of Hepatitis C Virus NS5A Resistance Associated Substitutions in Mainland China
by: Jie Lu, et al.
Published: (2019-03-01)

Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort
by: Ruben Brandão, et al.
Published: (2018-04-01)

Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil
by: Elisabete Andrade, et al.
Published: (2020-02-01)

Factors Influencing the Prevalence of Resistance-Associated Substitutions in NS5A Protein in Treatment-Naive Patients with Chronic Hepatitis C
by: Karen K. Kyuregyan, et al.
Published: (2020-04-01)

In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation
by: Samina Baig, et al.
Published: (2025-01-01)

A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome
by: Sabrina Bagaglio, et al.
Published: (2020-02-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
by: von Massow G, et al.
Published: (2019-04-01)

Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
by: Barbara Bartolini, et al.
Published: (2017-08-01)

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates
by: Sabrina Bagaglio, et al.
Published: (2018-09-01)

Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors
by: Jehad Hamdy, et al.
Published: (2022-05-01)

Comparative Analysis of NS5 Protein for Tick Borne Encephalitis Virus Strains in three Virus Subtypes
by: U. V. Potapova, et al.
Published: (2019-01-01)

Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
by: Marta Celegato, et al.
Published: (2023-02-01)

Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing NS5A inhibitors with sofosbuvir/velpatasvir plus ribavirin for 24 weeks
by: Sergii V. Fedorchenko, et al.
Published: (2023-06-01)

Phosphatidylinositol 4,5-Bisphosphate Is an HCV NS5A Ligand and Mediates Replication of the Viral Genome
by: Cho, Nam-Joon, et al.
Published: (2016)

Phosphatidylinositol 4,5-Bisphosphate Is an HCV NS5A Ligand and Mediates Replication of the Viral Genome
by: Cho, Nam-Joon, et al.
Published: (2016)

Membrane Retention of West Nile Virus NS5 Depends on NS1 or NS3 for Enzymatic Activity
by: Alanna C. Tseng, et al.
Published: (2024-08-01)

Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
by: Paul Alain Tagnouokam-Ngoupo, et al.
Published: (2019-08-01)

The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication
by: Tay, Moon Y. F., et al.
Published: (2018)

Induction of intrahepatic HCV NS4B, NS5A and NS5B-specific cellular immune responses following peripheral immunization.
by: Krystle A Lang Kuhs, et al.
Published: (2012-01-01)

Description of new maize hybrids: NS 5073, NS 5120, NS 5021 i NS ALEKSANDRA
by: Stojaković Milisav, et al.
Published: (2011-01-01)

MODIFICATIONS AND FREQUENCY OCCURRENCE OF GESTURES IN NS - NS AND NNS - NS DYADS
by: Juliana Wijaya
Published: (1999-01-01)

NS-NS spacetimes from amplitudes
by: Ricardo Monteiro, et al.
Published: (2022-06-01)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization.
by: Krystle A. Lang Kuhs, et al.
Published: (2013-01-01)

Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
by: Jenny Kouretova, et al.
Published: (2017-01-01)

HCV evolution and positive selection sites of HCV NS5B region among intravenous drug users in Guangdong
by: Min WANG, et al.
Published: (2022-06-01)

Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
by: Nurul Hanim Salin, et al.
Published: (2022-11-01)

Erp57 facilitates ZIKV-induced DNA damage via NS2B/NS3 complex formation
by: Yiran Wang, et al.
Published: (2024-12-01)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization
Published: (2013-01-01)

On NS-NS couplings at order α′3
by: Mohammad R. Garousi
Published: (2021-10-01)

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment
by: Amer F, et al.
Published: (2019-09-01)

Hypermultiplet metric and NS5-instantons
by: Sergei Alexandrov, et al.
Published: (2024-01-01)

A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication.
by: Olaf Isken, et al.
Published: (2015-03-01)

Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides Esters
by: Yu-Feng Lin, et al.
Published: (2024-12-01)

First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
by: Zahra Hasanshahi, et al.
Published: (2021-11-01)

Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs
by: Allan Peres-da-Silva, et al.
Published: (2012-03-01)

Evaluation of NS4A, NS4B, NS5 and 3′UTR Genetic Determinants of WNV Lineage 1 Virulence in Birds and Mammals
by: Lise Fiacre, et al.
Published: (2023-04-01)

Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication.
by: Olaf Isken, et al.
Published: (2016-01-01)

Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia
by: Vasily Isakov, et al.
Published: (2021-12-01)